CEO
Multiply Labs
Multiply Labs utilizes robotic systems to manufacture personalized pharmaceutical capsules and gene-modified cell therapies at industrial scale. Their technology enhances production efficiency and precision, ensuring that every patient has access to tailored, life-saving medications.
Traction 6/10Founded 2016
San Francisco, United States · HQ
- Biotechnology
- Manufacturing / Industry 4.0
- Robotics
Updated 3 days ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Problem
The production of personalized pharmaceutical capsules and gene-modified cell therapies often faces challenges in scalability, precision, and efficiency, hindering widespread access to tailored medications. Traditional manufacturing processes may struggle to meet the growing demand for individualized treatments while maintaining consistent quality and minimizing errors.
Solution
Multiply Labs offers robotic systems designed to automate and optimize the manufacturing of personalized pharmaceutical capsules and gene-modified cell therapies at an industrial scale. Their technology integrates with market-leading GMP instruments, providing a flexible and high-throughput solution for precision medicine production. By leveraging robotics and digital process control, Multiply Labs enhances production efficiency, ensures consistent quality, and enables real-time monitoring of critical process parameters. The system's digital QC capabilities provide comprehensive measurement and logging of all critical process parameters, both on-premises and in the cloud, while maintaining compatibility with leading GxP software systems.
Target Audience
Multiply Labs primarily serves pharmaceutical companies and life science organizations involved in the development and manufacturing of personalized medicines, including cell therapies and customized drug formulations.
Features
- Robotic systems compatible with market-leading GMP instruments
- Flexible module selection to match specific manufacturing processes
- High-throughput capabilities through parallel module operation
- Digital QC for real-time process control and comprehensive data logging
- On-premises and cloud-based operation for data management
- Compatibility with leading GxP software systems